Biotechnology's Chairman Board Sold: What Investors Know
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
This piece highlights why new investors favor index funds, emphasizing simplicity, cost efficiency, and dependable long-term results.
21,776 articlesInsider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
Opal Fuels is on investors’ radar for 2026. This guide breaks down the earnings landscape, core drivers, and how to e...
A bold take from Amazon's CEO on the AI era could shift how investors price the stock. This guide breaks down what an...
Rare-earths power modern magnets critical to tech, energy, and defense. This guide shows how to identify the best rar...
Stran’s Q1 2026 earnings reveal a mix of steady demand and evolving margins. This article breaks down the numbers, of...
A federal policy shift has just opened new doors for cannabis operators. For Green Thumb Industries and its investors...
A landmark analysis of Swedish twins suggests genetics may influence about 45% of how people invest, from trading fre...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
A Florence steakhouse reopened after five years closed, then a viral TikTok critique reshaped its fate. This personal...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
GE Vernova reports $18.3 billion in Q1 2026 orders and a $150 billion backlog, underscoring a durable AI-driven capex...